ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Project-002

Active
Institution
FRED HUTCHINSON CANCER CENTER, WA
Principal investigator
Leonidas Stamatatos
Funding
$216K
Duration
2023–2027
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract: The goals of Scientific Project Two are the manufacturing and release of two cGMP saRNA/NLC HIV-1 Env-derived vaccine candidates and the establishment of an ICH-compliant stability program for these vaccines. The two vaccines consist of a self-amplifying RNA (saRNA) encoding two HIV-1 Env immunogens (426c.Mod.Core and HxB2.WT.Core). The vaccines will be producing either the secreted nanoparticle form or the membrane-anchored forms of these two HIV-1 Env immunogens, depending on the findings made in Scientific Project One. The vaccines will be formulated with a nanostructured lipid carrier (NLC), which stabilizes the RNA and delivers it to cells that amplify it and express the antigen in vivo. The bulk drug substance (BDS) RNA is formulated with excipients, complexed with NLC BDS, sterile-filtered, and vialed to produce the final drug products (DP), which are the vaccine candidates. AAHI’s GMP Operations has experience with manufacturing and releasing saRNA and NLC BDS, and DPs or investigational Yellow Fever and SARS-CoV-2 vaccines. To date, AAHI GMP has manufactured four saRNA BDS, four NLC BDS, and two final drug products using our established processes. We are perfectly positioned to manufacture the HIV-1 Env immunogens discussed in this application within the period of funding.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESU19ZAI1-VS-Afinalvaccinesimmunogensvaccine candidatesgmphiv-envformulated

Questions for FRED HUTCHINSON CANCER CENTER

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.